Edition:
United Kingdom

Manojna Maddipatla

UPDATE 2-Biogen scraps two late-stage trials for Alzheimer's treatment

13 Sep 2019

Sept 13 Biogen Inc and Eisai Co Ltd are abandoning two late-stage trials for their Alzheimer's treatment in a widely anticipated move that comes months after the companies scrapped trials of another drug for the memory-robbing disease.

UPDATE 2-Tocagen's brain cancer treatment fails late-stage study, shares crash

12 Sep 2019

Sept 12 Tocagen Inc's shares fell nearly 80% after its experimental treatment failed to extend life of brain cancer patients in a study, the latest in a series of setbacks for patients awaiting new treatment options for the condition.

Mallinckrodt sells unit for up to $250 million, sees path forward to settle opioid lawsuits

10 Sep 2019

Mallinckrodt Plc shares surged more than 50% on Tuesday after it agreed to sell its contract manufacturing unit to reduce debt and its chief executive officer raised hopes that the company could reach a global settlement to resolve all opioid litigation.

Patent court to review Alexion's Soliris patents on Amgen challenge

31 Aug 2019

The U.S. patent office will review patents on Alexion Pharmaceuticals Inc's blood disorder treatment Soliris, after Amgen Inc challenged them, court filings showed on Friday.

Medtronic hits record high as profit beats, raises annual profit outlook

20 Aug 2019

Medtronic Plc beat analysts' estimates for quarterly profit on Tuesday, boosted by higher demand for its surgical instruments and diabetes devices, and the medical device maker raised its forecast for full-year adjusted profit as well.

UPDATE 1-Edwards Lifesciences, Medtronic heart valves win U.S. approval for expanded use

16 Aug 2019

Aug 16 Heart valve systems from Edwards Lifesciences Corp and Medtronic Plc have been approved for use in a condition that restricts blood flow from the heart in patients at low-risk of death linked to open-heart surgeries, the U.S. FDA said on Friday.

U.S. FDA approves TB Alliance's treatment for drug-resistant tuberculosis

14 Aug 2019

The U.S. Food and Drug Administration has approved TB Alliance's treatment for drug-resistant tuberculosis as part of a three-drug combination regimen called BPaL, the not-for-profit said on Wednesday.

FDA panel backs Gilead's HIV prevention drug Descovy, except in women

07 Aug 2019

An FDA advisory panel on Wednesday voted in favor of Gilead Sciences Inc's combination drug to reduce the risk of sexually acquired HIV infection in men and transgender women who have sex with men.

Centene signals higher costs in 2019 from Obamacare business

23 Jul 2019

Centene Corp beat second-quarter sales targets and raised its 2019 earnings forecast on Tuesday, but the health insurer warned of higher medical costs from its Obamacare business this year.

World News